Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7977091 Eukaryotic layered vector initiation systems

Patent 7977091 was granted and assigned to Novartis on July, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Thomas W. Dubensky, Jr.0

Douglas J Jolly0

John M Polo0

Stephen M. W. Chang0

Barbara A Belli0

Carlos E Ibanez0

David A Driver0

Date of Patent

July 12, 2011

Patent Application Number

12538494

Date Filed

August 10, 2009

Patent Citations Received

US Patent 11913001 Immunisation of large mammals with low doses of RNA

0

US Patent 11786467 Lipid formulations with immunogens

US Patent 11839686 Lipid formulations with viral immunogens

0

US Patent 11850305 Method of making lipid formulations with RNA encoding immunogens

0

US Patent 11851660 Immunisation of large mammals with low doses of RNA

0

US Patent 11857562 Delivery of RNA to trigger multiple immune pathways

0

US Patent 11857681 Lipid formulations with RNA encoding immunogens

0

US Patent 11865080 Delivery of RNA to trigger multiple immune pathways

0

...

Patent Primary Examiner

Michele K. Joike

Patent abstract

The present disclosure provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7977091 Eukaryotic layered vector initiation systems

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool